Implementation of a mathematical model for the photochemical kinetics of a solid form active pharmaceutical ingredient.


Chemical and Synthetic Development, Bristol-Myers Squibb, Co., One Squibb Dr., New Brunswick, NJ 08901, United States. Electronic address: [Email]


We present here the development of a photochemical model used to quantify the risk to photodegradation of a solid drug substance. A key feature of the proposed model development is streamlined estimation of the dependence of the absorption spectra and the quantum yield to the wavelength. A mathematical description of the relationship between the quantum yield and the wavelength enables estimation of photodegradation kinetics under any light anticipated to be encountered in the manufacturing environment. The system studied here consisted of a first order irreversible transformation (A → B(1Φ)) and the formalism strongly suggested the quantum yield was constant over the relevant wavelength range. The predictive power of the model enabled the design of a control strategy to limit the formation of the photo-degradant to very low levels. Also presented are insights obtained from quantum mechanical modeling of the electronic transitions associated with the UV absorption spectra.


Bulk API modeling,Confirmatory studies,Forced degradation studies,ICH Q1B,Manufacturing,Norrish type II,Norrish-Yang,Oral solids,Photostability studies,Photostability testing,

OUR Recent Articles